Idiopathic Hypogonadotropic Hypogonadism
10
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
10.0%
1 terminated out of 10 trials
85.7%
-0.8% vs benchmark
30%
3 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
Health Needs of Patients With Kallmann Syndrome
Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism
Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism
Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism
Effects of Medications in Patients With Hypogonadism
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders